MARKET

DRIO

DRIO

DarioHealth
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.88
+0.04
+0.29%
After Hours: 13.88 0 0.00% 16:14 09/24 EDT
OPEN
13.65
PREV CLOSE
13.84
HIGH
14.35
LOW
13.50
VOLUME
139.54K
TURNOVER
--
52 WEEK HIGH
31.85
52 WEEK LOW
10.01
MARKET CAP
229.15M
P/E (TTM)
-3.2051
1D
5D
1M
3M
1Y
5Y
DarioHealth to Participate in the Cantor Fitzgerald Virtual Global Healthcare Conference
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in a fireside chat during the Cantor Fitzgerald Virtual Global Healthcare Conference, which is being held September 27-3...
PR Newswire · 22h ago
Desperate for Solutions, Diabetes and Obesity Healthcare Sectors Find Answers, Hope in Innovative Tech
/PRNewswire/ -- Navigating today's healthcare systems can be overwhelming. Outrageous costs combined with complex processes have created a healthcare system renowned for overpriced inefficiency; PolicyAdvice reported that in 2018, the global healthcare mar...
PR Newswire - PRF · 1d ago
InvestorNewsBreaks DarioHealth Corp. (NASDAQ: DRIO) Exec Featured Speaker at American Health Insurance Plans National Conference
(MENAFN - Investor Brand Network) DarioHealth (NASDAQ: DRIO) , a pioneer in the global digital therapeutics market, has announced that chief medical officer Dr. Omar Manejwala will participate in the upcoming annual American Health Insurance Plans National...
MENAFN · 09/17 22:31
DarioHealth Chief Medical Officer Dr. Omar Manejwala to Speak at American Health Insurance Plans National Conference on Medicare, Medicaid and Dual Eligibles
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company's Chief Medical Officer, Dr. Omar Manejwala, will present at the annual American Health Insurance Plans National Conference on Medicare,...
PR Newswire · 09/17 10:40
BRIEF-DarioHealth Corp Enters Into Agreement To Provide Its Suite Of Digital Therapeutics To A Northeast Regional Employer
reuters.com · 09/09 11:08
DarioHealth Chosen by Northeast Regional Employer
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its suite of digital therapeutics for diabetes, hypertension and pre-diabetes to a ...
PR Newswire - PRF · 09/09 10:40
DarioHealth Wins Contract for Suite of Digital Therapeutics
MT Newswires · 09/09 08:27
InvestorNewsBreaks DarioHealth Corp. (NASDAQ: DRIO) Signs Behavioral Health Services Contract, Continues Growth in Employer Market
(MENAFN - Investor Brand Network)
MENAFN · 09/08 18:40
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DRIO. Analyze the recent business situations of DarioHealth through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DRIO stock price target is 27.53 with a high estimate of 35.00 and a low estimate of 12.75.
EPS
Institutional Holdings
Institutions: 70
Institutional Holdings: 9.09M
% Owned: 55.06%
Shares Outstanding: 16.51M
TypeInstitutionsShares
Increased
18
2.19M
New
24
1.12M
Decreased
12
185.87K
Sold Out
19
1.02M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Non-Executive Chairman/Independent Director
Yoav Shaked
President/General Manager
Richard Anderson
Chief Executive Officer/Director
Erez Raphael
Chief Financial Officer/Treasurer/Secretary
Zvi Ben-David
Chief Operating Officer
Dror Bacher
Senior Vice President/Director of Sales
Chris Chan
Vice President
Claudia Kraut
General Manager
Oded Cohen
Director
Adam Stern
Independent Director
Hila Karah
Independent Director
Dennis Matheis
Independent Director
Dennis Mcgrath
Independent Director
Richard Stone
No Data
About DRIO
DarioHealth Corp. (DarioHealth) is a Digital Therapeutics (DTx) company. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. The DTx products are centered around its users and include the Dario Blood Glucose Monitoring System and the Dario Smart Diabetes Management Solution, which are provided to its users in the form of a smartphone application that enables the delivery of content and periodical evidence-based reports; the DarioEngage platform, which provides support and two-way real-time connectivity between its users and their caregivers, and Dario Intelligence, which utilizes user data and is an analytics tool that can assist healthcare providers in the treatments and predictability of diseases. The Company’s services are available direct to consumers via online marketplaces including Amazon, Walmart, Best Buy and the Google and Apple app stores.

Webull offers kinds of DarioHealth Corp stock information, including NASDAQ:DRIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DRIO stock methods without spending real money on the virtual paper trading platform.